<DOC>
	<DOCNO>NCT02056496</DOCNO>
	<brief_summary>Pomegranate phenolic ( ellagitannin punicalagin ellagic acid ) metabolize human gut microbiota yield number metabolite call urolithins ( mainly Uro-A ) . Both ellagic acid ( EA ) urolithins exert number biological activity . However , bioavailability ellagic acid report low exist study controversial far . The investigator want carry robust ( cross-over , double-blind ) pharmacokinetic assay 20 healthy volunteer , use two type pomegranate extract ( PEs ) . PEs low ( PE-1 ) high ( PE-2 ) punicalagin : EA ratio administer . The investigator analyze blood urine sample use UPLC-ESI-QTOF-MS/MS . The investigator evaluate : - The pharmacokinetics EA . - The effect punicalagin : free EA ratio pharmacokinetics EA urolithins production .</brief_summary>
	<brief_title>Pharmacokinetics Bioavailability Pomegranate Phenolics Urolithins Healthy Subjects .</brief_title>
	<detailed_description />
	<criteria>Aged 1835 year . Healthy status ( illness previous 3months ) . Smoking . Pregnancy/lactation . Severe medical illness/chronic disease/ gastrointestinal pathology ( ulcer , irritable bowel syndrome , ulcerative colitis , Crohn disease etc. ) . Previous gastrointestinal surgery Recent use antibiotic ( within 1month prior study ) Suspected hypersensitivity pomegranate component Consumption nutraceuticals , botanical extract vitamin supplement take medication . Regular consumption ellagitannincontaining foodstuff ( walnut , pomegranate , strawberry , raspberry , oakaged red wine ) ( fill foodfrequency questionnaire ) . Intake ellagitanninscontaining foodstuff week pharmacokinetic intervention .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Pomegranate</keyword>
	<keyword>Ellagic acid</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Urolithins</keyword>
	<keyword>Bioavailability</keyword>
</DOC>